Log In
Print this Print this

Rotarix (formerly RIX4414)

  Manage Alerts
Collapse Summary General Information
Company Celldex Therapeutics Inc.
DescriptionOral attenuated rotavirus vaccine
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentMarketed
Standard IndicationRotavirus
Indication DetailsPrevent gastroenteritis due to rotavirus infection; Prevent rotavirus infection; Vaccinate against rotavirus; Vaccinate against severe rotavirus gastroenteritis
Regulatory Designation
PartnerDaiichi Sankyo Co. Ltd.;
GlaxoSmithKline plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
Get a free BioCentury trial today